PRTC
Income statement / Annual
Last year (2023), PureTech Health plc's total revenue was $3.33 M,
an increase of 59.33% from the previous year.
In 2023, PureTech Health plc's net income was -$65.70 M.
See PureTech Health plc’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$3.33 M
|
$2.09 M
|
$9.98 M
|
$8.34 M
|
$8.69 M
|
$16.37 M
|
$650,000.00
|
$4.43 M
|
$11.74 M
|
$2.01 M
|
Cost of Revenue |
$4.93 M |
$152.43 M |
$110.47 M |
$0.00 |
$85.85 M |
$77.40 M |
$71.04 M |
$1.57 M |
$740,000.00 |
$0.00 |
Gross Profit |
-$1.60 M |
-$150.34 M |
-$100.49 M |
$8.34 M |
-$77.16 M |
-$61.03 M |
-$70.39 M |
$2.86 M |
$11.00 M |
$2.01 M |
Gross Profit Ratio |
-0.48 |
-71.93 |
-10.07 |
1 |
-8.88 |
-3.73 |
-108.28 |
0.65 |
0.94 |
1 |
Research and Development
Expenses |
$96.24 M
|
$116.11 M
|
$81.52 M
|
$61.19 M
|
$65.17 M
|
$57.29 M
|
$71.67 M
|
$41.21 M
|
$13.41 M
|
$2.84 M
|
General & Administrative
Expenses |
$25.18 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
$7.17 M
|
Selling & Marketing
Expenses |
$23.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$48.36 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
$7.17 M
|
Other Expenses |
-$908,000.00 |
$48.12 M |
$47.98 M |
$40.19 M |
$44.03 M |
-$278,000.00 |
$14,000.00 |
$46,000.00 |
$448,000.00 |
$0.00 |
Operating Expenses |
$144.60 M |
$199.90 M |
$160.26 M |
$127.87 M |
$144.09 M |
$120.39 M |
$116.07 M |
$78.36 M |
$55.38 M |
$19.46 M |
Cost And Expenses |
$149.53 M |
$199.90 M |
$160.26 M |
$127.87 M |
$144.09 M |
$120.39 M |
$116.07 M |
$78.36 M |
$55.38 M |
$19.46 M |
Interest Income |
$16.01 M |
$5.80 M |
$214,000.00 |
$1.18 M |
$4.36 M |
$3.36 M |
$1.75 M |
$1.29 M |
$262,000.00 |
$46,000.00 |
Interest Expense |
$13.49 M |
$3.95 M |
$4.71 M |
$2.95 M |
$2.64 M |
$392,000.00 |
$553,000.00 |
$801,000.00 |
$835,000.00 |
$2.59 M |
Depreciation &
Amortization |
$4.93 M
|
$8.89 M
|
$7.24 M
|
$6.66 M
|
$6.67 M
|
$2.78 M
|
$2.10 M
|
$1.57 M
|
$740,000.00
|
$455,000.00
|
EBITDA |
-$141.27 M
|
-$202.72 M
|
-$214.90 M
|
-$144.76 M
|
-$94.85 M
|
-$123.93 M
|
-$138.67 M
|
-$77.39 M
|
-$45.38 M
|
-$16.94 M
|
EBITDA Ratio |
-42.42 |
-96.99 |
-21.53 |
-17.35 |
-10.92 |
-7.57 |
-213.34 |
-17.47 |
-3.87 |
-8.42 |
Operating Income Ratio
|
-43.9
|
-94.64
|
-15.06
|
-14.33
|
-15.58
|
-6.35
|
-177.57
|
-16.68
|
-3.72
|
-8.67
|
Total Other
Income/Expenses Net |
$143.78 M
|
$105.02 M
|
$91.33 M
|
$138.50 M
|
$613.87 M
|
$35.58 M
|
$44.71 M
|
-$9.25 M
|
-$12.68 M
|
-$58.78 M
|
Income Before Tax |
-$2.42 M |
-$92.78 M |
-$58.95 M |
$18.97 M |
$478.47 M |
-$68.44 M |
-$70.71 M |
-$83.18 M |
-$56.32 M |
-$76.22 M |
Income Before Tax Ratio
|
-0.73
|
-44.39
|
-5.91
|
2.27
|
55.07
|
-4.18
|
-108.79
|
-18.77
|
-4.8
|
-37.88
|
Income Tax Expense |
$30.53 M |
-$55.72 M |
$3.76 M |
$14.40 M |
$112.41 M |
$2.22 M |
-$14,000.00 |
-$1.57 M |
$1.92 M |
-$278,000.00 |
Net Income |
-$65.70 M |
-$37.06 M |
-$62.71 M |
$4.57 M |
$421.14 M |
-$43.65 M |
$30.87 M |
-$48.79 M |
-$39.39 M |
-$41.64 M |
Net Income Ratio |
-19.73 |
-17.73 |
-6.28 |
0.55 |
48.47 |
-2.67 |
47.49 |
-11.01 |
-3.36 |
-20.7 |
EPS |
-2.38 |
-1.3 |
-2.19 |
0.16 |
14.86 |
-1.59 |
1.3 |
-2.13 |
-2.13 |
-1.83 |
EPS Diluted |
-2.38 |
-1.3 |
-2.19 |
0.16 |
14.43 |
-1.59 |
1.3 |
-2.13 |
-2.13 |
-1.83 |
Weighted Average Shares
Out |
$27.63 M
|
$28.48 M
|
$28.66 M
|
$28.56 M
|
$28.34 M
|
$27.38 M
|
$23.55 M
|
$22.95 M
|
$18.53 M
|
$22.72 M
|
Weighted Average Shares
Out Diluted |
$27.63 M
|
$28.48 M
|
$28.66 M
|
$29.29 M
|
$29.18 M
|
$27.38 M
|
$23.89 M
|
$22.95 M
|
$18.53 M
|
$22.72 M
|
Link |
|
|
|
|
|
|
|
|
|
|